Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis
β Scribed by C. Colin; P. Vergnon; A. M. Jullien; S. Excoffier; Y. Matillon; C. Trepo; J. P. Aymard; D. Bastit; M. L. Bidet; R. Breviere; F. Chenais; F. Hau; D. Houssay; A. Mercadier; P. Maisonneuve; M. Lambert; C. Waller; D. Boudart; C. Cotte; M. H. Elghouzzi; C. Janot; M. Daudet; M. Menault; M. Montcharmont; W. Smilovici; C. Fretz; R. Follana; M. Doillon; J. C. Le Petit; P. Herve; B. Loyer; B. Mattlinger
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 792 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0934-9723
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
heart surgery at out institution were prospectively studied. Inclusion crit,eria were the following: absence of transfusion or acute hepatitis during the prior year, alcohol intake <80 gm per day. absence of the use of hepatotoxic drugs, normal aminotransferase values and negative hepatitis B virus
To assess the contribution of hepatitis C virus to non-A, non-B fulminant hepatitis in Japan, we compared 10 mqjor clinical features among 7 patients with type B fulminant hepatitis (type B group), 13 patients with non-A, non-B fulminant hepatitis with evidence of hepatitis C virus infection (type C